Previous work from Shalapour et al. demonstrated 138 + /IgA+ positive tumors were associated with immune-related treatment resistance and characterized how immunosuppressive plasma cells can impeded an anti-tumor T-cell response24. This evidence concerns the gene CD79A and neoplasm.